cardio oncology – risk prediction and surveillance for cardiotoxicity in cancer patients
Published 1 year ago • 597 plays • Length 17:34Download video MP4
Download video MP3
Similar videos
-
4:30
esc guidelines in cardio-oncology
-
51:43
cardiovascular risk in oncologic patients: one calculator does not fit all
-
10:24
role of cardioprotection in cancer therapy cardiotoxicity | jacc: cardiooncology author discussion
-
5:18
emerging cardio-oncology field targets breast cancer patients' risk for heart disease
-
1:00:34
cardio-oncology: what do we know beyond anthracycline cardiotoxicity, dr. lili zhang
-
57:44
cardio-oncology:mechanisms of cardiotoxicity and the evolving role of echocardiography
-
52:53
cardio-oncology in 2019
-
55:16
an update: what you should know about cardio oncology
-
1:01:02
cardio-oncology: understanding the connections between heart disease and cancer
-
56:25
cardio-oncology: what do we know beyond anthracycline cardiotoxicity? dr. lili zhang
-
55:08
cardiotoxicity of cancer therapies: a review for the oncology provider - b. c. jensen - 20211215
-
2:21:08
mount elizabeth hospitals ams 2022
-
1:01:00
“past, present and future ways to detect cardiotoxicity”
-
22:32
spotlight: risk prediction in breast cancer patients
-
3:56
cardio-oncology a-z: arrhythmias in cancer patients with dr michael fradley
-
56:28
the past, present, & future of cardiovascular care in the oncology patient
-
56:02
what you should know about cardio oncology
-
0:34
is everyone who receives radiation at risk for cardiotoxicity?